Belzutifan is a hypoxia-inducible factor-2α inhibitor that is US FDA approved for the treatment of VHL disease-associated renal cell carcinoma (RCC), CNS hemangioblastomas, or pancreatic ...

Von Hippel-Lindau (VHL) disease frequently leads to VHL-associated renal cell carcinoma (RCC), which carries a poor prognosis.

During a routine doctor's visit, Myers was informed she had only three years left to live due to Von Hippel-Lindau syndrome, a rare inherited disorder causing tumors and cysts to grow in her body.

How fast does kidney cancer spread, and what factors affect how quickly it spreads? Read on to learn more, including treatment options.

More than half of patients with VHL-associated RCC in a phase 2 trial remained on belzutifan treatment, with no new safety signals. Belzutifan, a hypoxia-inducible factor-2α inhibitor, durably ...

Democrat Julie von Haefen faces criticism after posting a video featuring an image of a beheaded Donald Trump during Raleigh’s downtown No Kings protest.

Von Hippel explained to me that the advantage of a consortium is that it allows nuclear experts from each country to “visit each other’s facilities to assure themselves that the activities are ...

Matt von Hippel is a freelance science writer based in Copenhagen, with a background in particle physics. His writing has been featured in Ars Technica and Scientific American. He blogs weekly at… ...

This type of kidney cancer may run in families and is associated with individuals who have a genetic condition called Von Hippel-Lindau syndrome and other hereditary conditions.

The University of California today (April 24) announced the 2025 cohort of UC President’s Lindau Nobel Laureate Meetings Fellows, 42 outstanding young scientists and economists from across the UC ...

From left: current Program on Science and Global Security co-directors Zia Mian and Alexander Glaser with founders Frank von Hippel and Harold Feiveson.

Belzutifan is an oral hypoxia-inducible factor inhibitor that is currently indicated for the treatment of von Hippel-Lindau disease and advanced renal cell carcinoma.